BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 24082309)

  • 1. Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome.
    Bayard S; Langenier MC; Dauvilliers Y
    Sleep; 2013 Oct; 36(10):1501-7. PubMed ID: 24082309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision making in restless legs syndrome.
    Bayard S; Yu H; Langenier MC; Carlander B; Dauvilliers Y
    Mov Disord; 2010 Nov; 25(15):2634-40. PubMed ID: 20669306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study.
    Cornelius JR; Tippmann-Peikert M; Slocumb NL; Frerichs CF; Silber MH
    Sleep; 2010 Jan; 33(1):81-7. PubMed ID: 20120624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compulsive habits in restless legs syndrome patients under dopaminergic treatment.
    Pourcher E; Rémillard S; Cohen H
    J Neurol Sci; 2010 Mar; 290(1-2):52-6. PubMed ID: 19969309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive function in patients with idiopathic Restless Legs Syndrome before and after treatment with dopamine-agonist.
    Galbiati A; Marelli S; Giora E; Zucconi M; Oldani A; Ferini-Strambi L
    Int J Psychophysiol; 2015 Mar; 95(3):304-9. PubMed ID: 25514234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of psychostimulants on impulsivity and risk taking in narcolepsy with cataplexy.
    Bayard S; Langenier MC; Dauvilliers Y
    Sleep; 2013 Sep; 36(9):1335-40. PubMed ID: 23997366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of dopamine agonists on compulsive behaviors: a case series of pramipexole-induced pathological gambling.
    Kolla BP; Mansukhani MP; Barraza R; Bostwick JM
    Psychosomatics; 2010; 51(3):271-3. PubMed ID: 20484726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations.
    Geyer J; Bogan R
    Postgrad Med; 2017 Sep; 129(7):667-675. PubMed ID: 28818004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological gambling plus hypersexuality in restless legs syndrome: a new case.
    d'Orsi G; Demaio V; Specchio LM
    Neurol Sci; 2011 Aug; 32(4):707-9. PubMed ID: 21567182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polysomnographic record and successful management of augmentation in restless legs syndrome/Willis-Ekbom disease.
    Maestri M; Fulda S; Ferini-Strambi L; Zucconi M; Marelli S; Staedler C; Bassetti CL; Manconi M
    Sleep Med; 2014 May; 15(5):570-5. PubMed ID: 24767724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].
    Bayard S; Cochen De Cock V; Dauvillers Y
    Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):227-35. PubMed ID: 21690031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. At-risk for pathological gambling: imaging neural reward processing under chronic dopamine agonists.
    Abler B; Hahlbrock R; Unrath A; Grön G; Kassubek J
    Brain; 2009 Sep; 132(Pt 9):2396-402. PubMed ID: 19567700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome.
    Driver-Dunckley ED; Noble BN; Hentz JG; Evidente VG; Caviness JN; Parish J; Krahn L; Adler CH
    Clin Neuropharmacol; 2007; 30(5):249-55. PubMed ID: 17909302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restless legs syndrome: clinical presentation diagnosis and treatment.
    Wijemanne S; Jankovic J
    Sleep Med; 2015 Jun; 16(6):678-90. PubMed ID: 25979181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term use of pramipexole in the management of restless legs syndrome.
    Lipford MC; Silber MH
    Sleep Med; 2012 Dec; 13(10):1280-5. PubMed ID: 23036265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs.
    Moore TJ; Glenmullen J; Mattison DR
    JAMA Intern Med; 2014 Dec; 174(12):1930-3. PubMed ID: 25329919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High national rates of high-dose dopamine agonist prescribing for restless legs syndrome.
    Winkelman JW
    Sleep; 2022 Feb; 45(2):. PubMed ID: 34417810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gambling addiction as a side effect of low dose pramipexole in the treatment of restless legs syndrome].
    Lindström ES; Ibsen JD; Skovbølling SL
    Ugeskr Laeger; 2022 Jun; 184(24):. PubMed ID: 35703072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A method to switch from oral dopamine agonists to rotigotine in patients with restless legs syndrome and mild augmentation.
    Winkelman JW; Mackie SE; Mei LA; Platt S; Schoerning L
    Sleep Med; 2016 Aug; 24():18-23. PubMed ID: 27810181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impulse control disorders in Parkinson's disease patients with RLS: a cross sectional-study.
    Marques A; Figorilli M; Pereira B; Derost P; Debilly B; Beudin P; Vidal T; Durif F; Fantini ML
    Sleep Med; 2018 Aug; 48():148-154. PubMed ID: 29913341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.